Clinical Research Directory
Browse clinical research sites, groups, and studies.
Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)
Sponsor: Institut Curie
Summary
ctDNA detection in patients with previously treated, HPV-induced, stage II or III invasive pelvic cancer and who are currently in post-treatment follow-up.
Official title: Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
172
Start Date
2019-01-24
Completion Date
2026-06-01
Last Updated
2025-09-15
Healthy Volunteers
No
Conditions
Interventions
Blood sampling
Patients will have a blood draw at each visit to the hospital and at least 6 months (+/- 1 month) intervals.
Locations (5)
CHU de Besançon
Besançon, France
Institut Curie - Paris
Paris, France
Hôpital Tenon
Paris, France
CHU Pontchaillou
Rennes, France
Institut Curie - Saint-Cloud
Saint-Cloud, France